Clinical Trial Update: Clarithromycin v Ciprofloxacin Added to Rifampicin + Ethambutol, for Opportunist Mycobacterial Pulmonary Disease [Phase 4]

View source ↗

Summary

This Phase 4 trial compared clarithromycin to ciprofloxacin when added to rifampicin plus ethambutol for opportunistic mycobacterial pulmonary disease and has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nontuberculous Mycobacterial Pulmonary Disease

Drugs mentioned

• Ciprofloxacin (Ciprofloxacin hydrochloride)
• Ethambutol (ethambutol)
• RIFAMPIN (RIFAMPIN)
• clarithromycin (clarithromycin)

Snippet

Sponsor: British Thoracic Society | Conditions: Pulmonary Diseases | Phase 4 | Status: COMPLETED